The risk/benefit of initiating ART in primary HIV infection (PHI) is unclear. The benefits are more likely to outweigh the risks in patients with severe PHI. An accepted definition of severe PHI is, however, lacking.
Lodi, S., Fisher, M., Phillips, A., De Luca, A., Ghosn, J., Malyuta, R., Zangerle, R., Moreno, S., Vanhems, P., Boufassa, F., Guiguet, M., Porter, K., Symptomatic illness and low CD4 cell count at HIV seroconversion as markers of severe primary HIV infection, <<PLOS ONE>>, 2013; 8 (11): e78642-e78642. [doi:10.1371/journal.pone.0078642] [http://hdl.handle.net/10807/54174]
Symptomatic illness and low CD4 cell count at HIV seroconversion as markers of severe primary HIV infection
De Luca, Andrea;
2013
Abstract
The risk/benefit of initiating ART in primary HIV infection (PHI) is unclear. The benefits are more likely to outweigh the risks in patients with severe PHI. An accepted definition of severe PHI is, however, lacking.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
unpaywall-bitstream-2079704711.pdf
accesso aperto
Tipologia file ?:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
226.76 kB
Formato
Adobe PDF
|
226.76 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
